Stock listing
NASDAQ:INAB IN8bio, Inc. Stock
Home listing (NASDAQ) of IN8bio, Inc.
Follow IN8bio, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:INAB
$0.96 USD -0.01 (-0.6%)
Close on Oct 27, 2026
- Day range
- $0.931 – $0.991 USDOct 27, 2026
- Volume
- 12,197 sharesOct 27, 2026
- Market cap
- $9.46M USDAt the close on Oct 27, 2026 · price × 9.86M shares outstanding
- 52-week range
- $0.87 – $2.73 USDLowest and highest trades, Oct 28, 2025 – Oct 27, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:INAB · Home | $0.96 USD | -0.006 (-0.6%) | 12,197 | $0.931 | $0.991 | $0.931 | $0.966 | Close on Oct 27, 2026 |
| Frankfurt:6JH0 | €0.81 EUR | -0.055 (-6.4%) | — | €0.81 | €0.81 | €0.81 | €0.865 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 27, 2026 – Oct 27, 2026 · NASDAQ:INAB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.96 | -0.006 | -0.6% | $0.931 | $0.991 | $0.931 | 12,197 | |
| $0.966 | -0.085 | -8.0% | $0.97 | $1.04 | $0.87 | 183,132 | |
| $1.05 | +0.064 | +6.5% | $1.02 | $1.079 | $1.018 | 10,300 | |
| $0.986 | -0.104 | -9.5% | $1.06 | $1.09 | $0.976 | 44,100 | |
| $1.09 | -0.05 | -4.4% | $1.16 | $1.16 | $1.05 | 32,200 | |
| $1.14 | +0.05 | +4.6% | $1.10 | $1.175 | $1.10 | 2,400 | |
| $1.09 | -0.02 | -1.8% | $1.11 | $1.174 | $1.07 | 21,500 | |
| $1.11 | -0.075 | -6.3% | $1.17 | $1.18 | $1.06 | 31,700 | |
| $1.185 | -0.015 | -1.2% | $1.209 | $1.235 | $1.17 | 9,800 | |
| $1.20 | +0.02 | +1.7% | $1.185 | $1.23 | $1.135 | 73,600 | |
| $1.18 | -0.05 | -4.1% | $1.25 | $1.26 | $1.18 | 62,700 | |
| $1.23 | -0.11 | -8.2% | $1.359 | $1.36 | $1.225 | 31,800 | |
| $1.34 | -0.04 | -2.9% | $1.36 | $1.38 | $1.34 | 13,100 | |
| $1.38 | -0.02 | -1.4% | $1.40 | $1.40 | $1.33 | 22,200 | |
| $1.40 | +0.01 | +0.7% | $1.38 | $1.41 | $1.36 | 20,700 | |
| $1.39 | -0.03 | -2.1% | $1.425 | $1.45 | $1.35 | 45,600 | |
| $1.42 | +0.02 | +1.4% | $1.43 | $1.45 | $1.38 | 107,100 | |
| $1.40 | 0.00 | 0.0% | $1.42 | $1.46 | $1.342 | 39,500 | |
| $1.40 | +0.07 | +5.3% | $1.36 | $1.46 | $1.36 | 78,500 | |
| $1.33 | +0.035 | +2.7% | $1.31 | $1.362 | $1.31 | 30,300 | |
| $1.295 | +0.055 | +4.4% | $1.28 | $1.30 | $1.27 | 62,200 | |
| $1.24 | +0.04 | +3.3% | $1.19 | $1.30 | $1.19 | 74,300 | |
| $1.20 | +0.01 | +0.8% | $1.18 | $1.27 | $1.17 | 67,600 | |
| $1.19 | +0.09 | +8.2% | $1.111 | $1.25 | $1.10 | 180,000 | |
| $1.10 | -0.04 | -3.5% | $1.15 | $1.15 | $1.10 | 22,600 | |
| $1.14 | +0.08 | +7.5% | $1.06 | $1.16 | $1.06 | 41,600 | |
| $1.06 | -0.02 | -1.9% | $1.09 | $1.11 | $1.06 | 13,800 | |
| $1.08 | +0.01 | +0.9% | $1.05 | $1.08 | $1.03 | 20,300 | |
| $1.07 | +0.06 | +5.9% | $1.03 | $1.10 | $1.03 | 48,000 | |
| $1.01 | -0.04 | -3.8% | $1.06 | $1.09 | $1.01 | 29,300 | |
| $1.05 | -0.06 | -5.4% | $1.10 | $1.10 | $1.01 | 70,900 | |
| $1.11 | +0.04 | +3.7% | $1.11 | $1.14 | $1.07 | 20,100 | |
| $1.07 | -0.03 | -2.7% | $1.12 | $1.13 | $1.06 | 37,000 | |
| $1.10 | +0.02 | +1.9% | $1.08 | $1.11 | $1.08 | 15,600 | |
| $1.08 | -0.06 | -5.3% | $1.10 | $1.125 | $1.08 | 21,500 | |
| $1.14 | -0.06 | -5.0% | $1.20 | $1.20 | $1.13 | 31,400 | |
| $1.20 | +0.04 | +3.4% | $1.16 | $1.22 | $1.16 | 22,400 | |
| $1.16 | +0.06 | +5.5% | $1.10 | $1.16 | $1.096 | 41,500 | |
| $1.10 | +0.01 | +0.9% | $1.09 | $1.11 | $1.085 | 6,700 | |
| $1.09 | -0.01 | -0.9% | $1.10 | $1.13 | $1.08 | 19,900 | |
| $1.10 | +0.065 | +6.3% | $1.01 | $1.13 | $1.01 | 36,900 | |
| $1.035 | -0.005 | -0.5% | $1.04 | $1.05 | $1.03 | 24,100 | |
| $1.04 | -0.145 | -12.2% | $1.19 | $1.19 | $0.96 | 130,300 | |
| $1.185 | +0.015 | +1.3% | $1.17 | $1.20 | $1.165 | 3,300 | |
| $1.17 | -0.01 | -0.8% | $1.18 | $1.20 | $1.11 | 58,728 | |
| $1.18 | -0.10 | -7.8% | $1.30 | $1.30 | $1.145 | 72,786 | |
| $1.28 | +0.07 | +5.8% | $1.23 | $1.30 | $1.18 | 105,500 | |
| $1.21 | +0.01 | +0.8% | $1.22 | $1.255 | $1.17 | 17,200 | |
| $1.20 | +0.06 | +5.3% | $1.16 | $1.26 | $1.155 | 79,100 | |
| $1.14 | +0.03 | +2.7% | $1.135 | $1.17 | $1.13 | 45,300 | |
| $1.11 | +0.01 | +0.9% | $1.11 | $1.14 | $1.052 | 37,000 | |
| $1.10 | -0.08 | -6.8% | $1.19 | $1.20 | $1.10 | 56,000 | |
| $1.18 | +0.181 | +18.1% | $0.999 | $1.19 | $0.94 | 375,500 | |
| $0.999 | -0.051 | -4.9% | $1.07 | $1.075 | $0.88 | 90,200 | |
| $1.05 | +0.074 | +7.6% | $1.00 | $1.05 | $0.98 | 57,920 | |
| $0.976 | -0.003 | -0.3% | $0.98 | $1.01 | $0.958 | 67,434 | |
| $0.979 | +0.009 | +0.9% | $0.97 | $0.98 | $0.951 | 36,600 | |
| $0.97 | -0.019 | -1.9% | $0.989 | $0.989 | $0.90 | 76,900 | |
| $0.989 | +0.029 | +3.0% | $1.00 | $1.00 | $0.94 | 39,800 | |
| $0.96 | 0.00 | 0.0% | $0.99 | $0.991 | $0.94 | 37,700 | |
| $0.96 | -0.075 | -7.2% | $1.08 | $1.08 | $0.94 | 152,100 | |
| $1.035 | -0.045 | -4.2% | $1.08 | $1.08 | $1.01 | 57,600 | |
| $1.08 | +0.01 | +0.9% | $1.055 | $1.08 | $0.96 | 82,600 | |
| $1.07 | -0.04 | -3.6% | $1.115 | $1.126 | $1.055 | 58,100 | |
| $1.11 | -0.08 | -6.7% | $1.179 | $1.179 | $1.10 | 81,700 | |
| $1.19 | -0.01 | -0.8% | $1.23 | $1.24 | $1.18 | 30,600 |
- Ticker
- NASDAQ:INAB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 6, 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Calls
Replays
In8bio (NASDAQ:INAB) Q1 2022 Earnings Call
Tue, May 17, 2022 · 6:00 PM ET
Watch Transcript
Latest news
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 6, 2026
Closed $1.40 (+0.7%) on Oct 7, 2026
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026
Closed $1.10 (+1.9%) on Sep 10, 2026
IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
Sep 9, 2026
Closed $1.08 (-5.3%) on Sep 9, 2026
IN8bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)
Aug 11, 2026
Closed $1.05 (+7.6%) on Aug 11, 2026
IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 6, 2026
Closed $0.979 (+0.9%) on Aug 7, 2026
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
Jul 9, 2026
Closed $1.40 (+1.4%) on Jul 9, 2026
IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
Jun 3, 2026
Closed $1.54 (-1.3%) on Jun 3, 2026
IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
Jun 1, 2026
Closed $1.73 (-7.5%) on Jun 1, 2026
IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
May 14, 2026
Closed $1.59 (0.0%) on May 14, 2026
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026
Closed $1.58 (-1.3%) on May 8, 2026
Decks
Investor Presentation (2024)
Investor deck · 56 slides · 2024
IN8bio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 116 in all · newest Oct 6, 2026 · oldest 2021
- Calls
- 1 call with a replay · 1 with a transcript · latest May 17, 2022
- Decks
- 1 deck · latest 2024
Where IN8bio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:INAB · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A4197Y | LS Exchange | Germany | EUR |
| BOATS:INAB | BOATS | United States | USD |
| gettex:6JH0 | gettex | Germany | EUR |
| Lang & Schwarz:A4197Y | Lang & Schwarz | Germany | EUR |
| Dusseldorf:6JH0 | Dusseldorf | Germany | EUR |
| Frankfurt:6JH0 | Frankfurt | Germany | EUR |
| Munich:6JH0 | Munich | Germany | EUR |
| Stuttgart:6JH0 | Stuttgart | Germany | EUR |
| Tradegate:6JH0 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about IN8bio, Inc.